137 related articles for article (PubMed ID: 38346003)
21. Antiplatelet effects of the CEACAM1-derived peptide QDTT.
Ye Y; Leng M; Chai S; Yang L; Ren L; Wan W; Wang H; Li L; Li C; Meng Z
Platelets; 2024 Dec; 35(1):2308635. PubMed ID: 38345065
[TBL] [Abstract][Full Text] [Related]
22. Identification of allelic variants of the bovine immune regulatory molecule CEACAM1 implies a pathogen-driven evolution.
Kammerer R; Popp T; Singer BB; Schlender J; Zimmermann W
Gene; 2004 Sep; 339():99-109. PubMed ID: 15363850
[TBL] [Abstract][Full Text] [Related]
23. The tumour suppressor gene CEACAM1 is completely but reversibly downregulated in renal cell carcinoma.
Kammerer R; Riesenberg R; Weiler C; Lohrmann J; Schleypen J; Zimmermann W
J Pathol; 2004 Nov; 204(3):258-67. PubMed ID: 15476270
[TBL] [Abstract][Full Text] [Related]
24. Characterization of murine CEACAM1
McLeod RL; Angagaw MH; Baral TN; Liu L; Moniz RJ; Laskey J; Hsieh S; Lee M; Han JH; Issafras H; Javaid S; Loboda A; Sadekova S; O'Connor JA; Tse A; Punnonen J
Oncotarget; 2018 Oct; 9(77):34459-34470. PubMed ID: 30349641
[TBL] [Abstract][Full Text] [Related]
25. cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function.
Izzi L; Turbide C; Houde C; Kunath T; Beauchemin N
Oncogene; 1999 Sep; 18(40):5563-72. PubMed ID: 10523833
[TBL] [Abstract][Full Text] [Related]
26. Carcinoembryonic antigen cell adhesion molecule 1 directly associates with cytoskeleton proteins actin and tropomyosin.
Schumann D; Chen CJ; Kaplan B; Shively JE
J Biol Chem; 2001 Dec; 276(50):47421-33. PubMed ID: 11595750
[TBL] [Abstract][Full Text] [Related]
27. Carcinoembryonic antigen-related cell adhesion molecule 1 on murine dendritic cells is a potent regulator of T cell stimulation.
Kammerer R; Stober D; Singer BB; Obrink B; Reimann J
J Immunol; 2001 Jun; 166(11):6537-44. PubMed ID: 11359805
[TBL] [Abstract][Full Text] [Related]
28. Soluble isoforms of CEACAM1 containing the A2 domain: increased serum levels in patients with obstructive jaundice and differences in 3-fucosyl-N-acetyl-lactosamine moiety.
Dráberová L; Cerná H; Brodská H; Boubelík M; Watt SM; Stanners CP; Dráber P
Immunology; 2000 Oct; 101(2):279-87. PubMed ID: 11012782
[TBL] [Abstract][Full Text] [Related]
29. Isolation of a new human scFv antibody recognizing a cell surface binding site to CEACAM1. Large yield production, purification and characterization in E. coli expression system.
Moricoli D; Laguardia ME; Carbonella DC; Balducci MC; Dominici S; Fiori V; Serafini G; Flego M; Cianfriglia M; Magnani M
Protein Expr Purif; 2014 Jan; 93():38-45. PubMed ID: 24184403
[TBL] [Abstract][Full Text] [Related]
30. Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits proximal TCR signaling by targeting ZAP-70.
Chen Z; Chen L; Qiao SW; Nagaishi T; Blumberg RS
J Immunol; 2008 May; 180(9):6085-93. PubMed ID: 18424730
[TBL] [Abstract][Full Text] [Related]
31. [CEACAM1--a less well-known member of the family of carcinoembryonic antigens].
Muchová L; Vítek L; Jirsa M
Cas Lek Cesk; 2003; 142(5):259-63. PubMed ID: 12920788
[TBL] [Abstract][Full Text] [Related]
32. Role of Ceacam1 in VEGF induced vasculogenesis of murine embryonic stem cell-derived embryoid bodies in 3D culture.
Gu A; Tsark W; Holmes KV; Shively JE
Exp Cell Res; 2009 Jun; 315(10):1668-82. PubMed ID: 19285068
[TBL] [Abstract][Full Text] [Related]
33. The role of carcinoembryonic antigen-related cell adhesion molecule 1 in cancer.
Götz L; Rueckschloss U; Balk G; Pfeiffer V; Ergün S; Kleefeldt F
Front Immunol; 2023; 14():1295232. PubMed ID: 38077351
[TBL] [Abstract][Full Text] [Related]
34. Cytokine-induced CEACAM1 expression on keratinocytes is characteristic for psoriatic skin and contributes to a prolonged lifespan of neutrophils.
Rahmoun M; Molès JP; Pedretti N; Mathieu M; Fremaux I; Raison-Peyron N; Lecron JC; Yssel H; Pène J
J Invest Dermatol; 2009 Mar; 129(3):671-81. PubMed ID: 18843289
[TBL] [Abstract][Full Text] [Related]
35. Specific regulation of T helper cell 1-mediated murine colitis by CEACAM1.
Iijima H; Neurath MF; Nagaishi T; Glickman JN; Nieuwenhuis EE; Nakajima A; Chen D; Fuss IJ; Utku N; Lewicki DN; Becker C; Gallagher TM; Holmes KV; Blumberg RS
J Exp Med; 2004 Feb; 199(4):471-82. PubMed ID: 14970176
[TBL] [Abstract][Full Text] [Related]
36. CEACAM1 is overexpressed in oral tumors and related to tumorigenesis.
Wang FF; Guan BX; Yang JY; Wang HT; Zhou CJ
Med Mol Morphol; 2017 Mar; 50(1):42-51. PubMed ID: 27464654
[TBL] [Abstract][Full Text] [Related]
37. Preclinical Activity of SAR408701: A Novel Anti-CEACAM5-maytansinoid Antibody-drug Conjugate for the Treatment of CEACAM5-positive Epithelial Tumors.
Decary S; Berne PF; Nicolazzi C; Lefebvre AM; Dabdoubi T; Cameron B; Rival P; Devaud C; Prades C; Bouchard H; Cassé A; Henry C; Amara C; Brillac C; Ferrari P; Maçon L; Lacoste E; Combeau C; Beys E; Naimi S; García-Echeverría C; Mayaux JF; Blanc V
Clin Cancer Res; 2020 Dec; 26(24):6589-6599. PubMed ID: 33046521
[TBL] [Abstract][Full Text] [Related]
38. A novel anti-CEACAM5 monoclonal antibody, CC4, suppresses colorectal tumor growth and enhances NK cells-mediated tumor immunity.
Zheng C; Feng J; Lu D; Wang P; Xing S; Coll JL; Yang D; Yan X
PLoS One; 2011; 6(6):e21146. PubMed ID: 21731662
[TBL] [Abstract][Full Text] [Related]
39. Combined Blockade of T Cell Immunoglobulin and Mucin Domain 3 and Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Results in Durable Therapeutic Efficacy in Mice with Intracranial Gliomas.
Li J; Liu X; Duan Y; Liu Y; Wang H; Lian S; Zhuang G; Fan Y
Med Sci Monit; 2017 Jul; 23():3593-3602. PubMed ID: 28736431
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
